fda glp-1 warning letters november 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Letter to Fox Corporation regarding

Notably, the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial, the first dedicated kidney outcome trial evaluating canagliflozin in people with type 2 diabetes mellitus and CKD, demonstrated a substantial reduction in the risk of kidney events [46]

First-month ads promote a $39 starting price, which reflects a discounted membership fee only

Dose adjustments are common, and your doctor should monitor blood pressure monthly during GLP-1 treatment, especially in the first 3-6 months when weight loss is most rapid

In times of stress, illness, or intense physical activity, glutathione levels can drop, leaving your immunity compromised